Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysis
{{output}}
IntroductionAlpelisib exhibits variability in length of drug exposure and clinical safety outside of clinical trials. This study aimed to bridge the gap between clinical trial outcomes and real-world evidence by quantifying the Time on Therapy (TOT) and examin... ...
